Simultaneous 99mTC and 123I Dual-Isotope Brain Striatal Phantom Single Photon Emission Computed Tomography: Validation of 99mTC-Trodat-1 and 123I-IBZM Simultaneous Dopamine System Brain Imaging

Kaohsiung Journal of Medical Sciences

Volumn 25, Issue 11, 2009, Pages 601-607

  Kao, Pan Fu ^a,b   Wey, Shiaw Pyng ^c   Yang, An Shoei ^d  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

^d INSTITUTE OF NUCLEAR ENERGY RESEARCH   (Taiwan)

Author keywords

123I IBZM; 99mTc TRODAT 1; brain striatal phantom; SPECT

Indexed keywords

[2 [[2 [[[3 (4 CHLOROPHENYL) 8 METHYL 8 AZABICYCLO[3.2.1]OCT 2 YL]METHYL](2 MERCAPTOETHYL)AMINO]ETHYL]AMINO]ETHANETHIOLATO]OXOTECHNETIUM TC 99M; IODINE 123; IODOBENZAMIDE I 123; RADIOISOTOPE; TECHNETIUM 99M; UNCLASSIFIED DRUG; 3 IODO 2 HYDROXY 6 METHOXY N ((1 ETHYL 2 PYRROLIDINYL)METHYL)BENZAMIDE; 3-IODO-2-HYDROXY-6-METHOXY-N-((1-ETHYL-2-PYRROLIDINYL)METHYL)BENZAMIDE; BENZAMIDE DERIVATIVE; DIAGNOSTIC AGENT; DOPAMINE; PYRROLIDINE DERIVATIVE; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M TRODAT 1; TECHNETIUM TC 99M TRODAT-1; TROPANE DERIVATIVE;

ARTICLE; CALCULATION; CLINICAL EVALUATION; CLINICAL PRACTICE; CORPUS STRIATUM; CORRELATIONAL STUDY; DIAGNOSTIC IMAGING; DOPAMINERGIC SYSTEM; ENERGY; EXPERIMENT; INFORMATION PROCESSING; MOTOR DYSFUNCTION; PARAMETER; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VALIDATION STUDY; BRAIN; HUMAN; IMAGE QUALITY; INSTRUMENTATION; METABOLISM; METHODOLOGY; SCINTISCANNING;

BENZAMIDES; BRAIN; DOPAMINE; HUMANS; IODINE RADIOISOTOPES; ORGANOTECHNETIUM COMPOUNDS; PHANTOMS, IMAGING; PYRROLIDINES; RADIOISOTOPES; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 70350484996     PISSN: 1607551X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1607-551X(09)70563-7     Document Type: Article

References (13)

1. Berman D.S., Kiat H., Van Train K., et al. Dual-isotope myocardial perfusion SPECT with rest thallium-201 and stress Tc-99m sestamibi. Cardiol Clin 12 (1994) 261-270
2. Kiat H., Germano G., Friedman J., et al. Comparative feasibility of separate or simultaneous rest thallium201/stress technetium-99m-sestamibi dual-isotope myocardial perfusion SPECT. J Nucl Med 35 (1994) 542-548
3. Devous M.D., Payne J.K., and Lowe J.L. Dual-isotope brain SPECT imaging with technetium-99m and iodine-123: clinical validation using xenon-133 SPECT. J Nucl Med 33 (1992) 1919-1924
4. Devous M.D., Lowe J.L., and Payne J.K. Dual-isotope brain SPECT imaging with technetium-99m and iodine-123: validation by phantom studies. J Nucl Med 33 (1992) 2030-2035
5. Kumita S., Cho K., Nakajo H., et al. Simultaneous assessment of Tc-99m-sestamibi and I-123-BMIPP myocardial distribution in patients with myocardial infarction: evaluation of left ventricular function with ECG-gated myocardial SPECT. Ann Nucl Med 14 (2000) 453-459
6. Ivanovic M., Weber D.A., Loncaric S., et al. Feasibility of dual radionuclide brain imaging with I-123 and Tc-99m. Med Phys 21 (1994) 667-674
7. El Fakhri G., Moore S.C., Maksud P., et al. Absolute activity quantitation in simultaneous 123I/99mTc brain SPECT. J Nucl Med 42 (2001) 300-308
8. Kung H.F., Kim H.J., Kung M.P., et al. Imaging of dopamine transporters in humans with technetium-99m TRODAT-1. Eur J Nucl Med 23 (1996) 1527-1530
9. 2 dopamine receptor imaging agent. J Nucl Med 32 (1991) 339-342
10. Dresel S.H., Kung M.P., Huang X.F., et al. Simultaneous SPECT studies of preand postsynaptic dopamine binding sites in baboons. J Nucl Med 40 (1999) 660-666
11. Ma K.H., Huang W.S., Chen C.H., et al. Dual SPECT of dopamine system using [99mTc]TRODAT-1 and [123I]IBZM in normal and 6-OHDA-lesioned Formosan rock monkeys. Nucl Med Biol 29 (2002) 561-567
12. Hashimoto M., Kawasaki K., Suzuki M., et al. Presynaptic and postsynaptic nigrostriatal dopaminergic functions in multiple system atrophy. Neuroreport 19 (2008) 145-150
13. Kao P.F., Tzen K.Y., Yen T.C., et al. The optimal imaging time for [99mTc]TRODAT-1/SPET in normal subjects and patients with Parkinson's disease. Nucl Med Commun 22 (2001) 151-154